Last reviewed · How we verify
NCT04390282: PRESIC
Secondary Prevention and Application-based Lifestyle Support for Patients With Intermittent Claudication
NA trial testing Application-based support system in Intermittent Claudication in 30 participants. Completed in 28 February 2022.
22 February 2022
Quick facts
| Lead sponsor | Malmö University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 September 2021 |
| Primary completion | 22 February 2022 |
| Estimated completion | 28 February 2022 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Application-based support system
Conditions studied
- Intermittent Claudication — all drugs for Intermittent Claudication →
- Vascular Diseases — all drugs for Vascular Diseases →
Sponsor
Malmö University
Who can join
18 and older, any sex, with Intermittent Claudication or Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized controlled pilot trial will be used to test Lifepod®PAD as secondary prevention support system. Approximately 60 patients with intermittent claudication at the Department of vascular diseases at Skåne University hospital will be invited. The intervention group (n=30) will test Lifepod PAD for 3 months and the control group (n=30) will receive secondary prevention as usual. Primary outcome is pain free walking distance and secondary outcomes will be quality of life, illness perception, ankle brachial pressure, self-efficacy, adherence to medical treatment and blood pressure. Acceptability, delivery of the intervention, expected sample size and effect size, procedure of randomization and follow-ups will be evaluated. The outcome will be used to design a main randomized trial. Combinations of quantitative measures and qualitative interviews will be used to understand the process in detail.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04390282
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intermittent Claudication
Currently open trials in the same condition.
- NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
- NCT06657976 — Response to Exercise and Nitric Oxide in PAD · Phase 2 · recruiting
- NCT05457738 — Home-based Exercice Therapy for Patients With Intermittent Claudication Using a New Smartphone Application · NA · recruiting
- NCT06114732 — Motivating Physical Activity With Behavioural interVention and Electrical Stimulation Remotely in Intermittent Claudicat · NA · recruiting
- NCT05132439 — MetfOrmin BenefIts Lower Extremities With Intermittent Claudication · Phase 3 · recruiting
Other Malmö University trials
Trials by the same sponsor.
- NCT07390019 — Families Experiencing Cancer - Support to Prevent Cancer-related Illness · NA · not yet recruiting
- NCT07344909 — Burning Mouth Syndrome: Effects of Occlusal Splint Therapy · NA · not yet recruiting
- NCT07095101 — ePROPP - eHealth for Preventing and Reducing Orofacial Pain in the Population · NA · not yet recruiting
- NCT07266701 — The General Aim is to Implement Clinical Assessment of Overload by Voluntary Bite Force Registration to Enable Future Si · enrolling by invitation
- NCT06833034 — Comparing a Novel Closed Exposure Technique to a Conventional Method for Palatally Impacted Maxillary Canines · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04390282 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Malmö University
- Last refreshed: 18 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04390282.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing